Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
HELIUS MEDICAL TECHNOLOGIES, INC. (HSDT)
|
Add to portfolio |
|
|
|
| Price: |
$5.35
| | Metrics |
| OS: |
28.3
|
M
| |
-220
|
% ROE
|
| Market cap: |
$151
|
M
| |
-1386
|
% ROIC
|
|
Net cash:
|
$8.6
|
M
| |
$0.30
|
per share
|
|
EV:
|
$143
|
M
| | | |
| | | | | |
| TTM Valuation | | | |
|
EBITDA
|
($13.6)
|
M
| |
|
|
|
EBIT
|
($13.8)
|
M
| |
|
|
| EPS |
($0.63)
| |
|
|
|
|
| |
|
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
| In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Mar-31-16 | Mar-31-15 |
| Revenues | 0.8 | 0.5 | 0.7 | 1.5 | 0.5 | 0.0 | 18.6 | 0.0 |
| Revenue growth | 50.8% | -21.0% | -55.8% | 213.0% | | | | |
| Cost of goods sold | 0.5 | 0.3 | 0.4 | 0.8 | 0.0 | 0.0 | 0.0 | 0.0 |
| Gross profit | 0.3 | 0.2 | 0.3 | 0.7 | 0.5 | 0.0 | 18.6 | 0.0 |
| Gross margin | 41.2% | 42.9% | 41.3% | 43.4% | 100.0% | | 100.0% | |
| Selling, general and administrative | 10.6 | 12.2 | 9.7 | 16.5 | 17.2 | | | |
| Research and development | 4.3 | 6.0 | 4.6 | 8.1 | 9.9 | 14.4 | 3.6 | 4.5 |
| General and administrative | | | | | | 8.5 | 5.7 | 5.3 |
| EBITA | -14.6 | -17.9 | -14.0 | -23.9 | -26.7 | -22.9 | 9.3 | -9.8 |
| EBITA margin | -1852.4% | -3437.2% | -2121.5% | -1599.7% | -5580.5% | | 50.0% | |
| Amortization of intangibles | 0.2 | 0.2 | 0.4 | 0.1 | | | | |
| EBIT | -14.8 | -18.1 | -14.4 | -24.0 | -26.7 | -22.9 | 9.3 | -9.8 |
| EBIT margin | -1875.3% | -3475.5% | -2176.4% | -1604.0% | -5580.5% | | 50.0% | |
| Pre-tax income | -14.1 | -18.1 | -14.1 | 9.8 | 28.6 | 28.0 | -6.9 | -9.8 |
| Income taxes | 0.0 | 0.0 | 0.0 | 0.0 | 57.2 | 56.0 | 0.0 | 0.0 |
| Tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 200.0% | 200.0% | 0.0% | 0.0% |
| Net income | -14.1 | -18.1 | -14.1 | -9.8 | -28.6 | -28.0 | -6.9 | -9.8 |
| Net margin | -1788.1% | -3473.6% | -2137.7% | -653.8% | -5988.1% | | -36.9% | |
| |
| Diluted EPS | ($1.04) | ($7.38) | ($11.80) | ($12.99) | ($1.26) | ($1.50) | ($0.10) | ($0.17) |
| Shares outstanding (diluted) | 13.5 | 2.5 | 1.2 | 0.8 | 22.8 | 18.6 | 67.0 | 57.0 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|